Teligent
TLGT
#10190
Rank
C$22.02 M
Marketcap
C$0.23
Share price
-13.85%
Change (1 day)
1,536.17%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -C$56.01 Million

According to Teligent's latest financial reports the company's current earnings are C$46.29 Million. In 2020 the company made an earning of -C$52.54 Million a decrease over its 2019 earnings that were of -C$10.97 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$56.01 Million6.61%
2020-C$52.54 Million378.89%
2019-C$10.97 Million-46.87%
2018-C$20.65 Million10.47%
2017-C$18.69 Million-637.49%
2016C$3.47 M-179.64%
2015-C$4.37 Million-181.72%
2014C$5.34 M-4806.02%
2013-C$0.12 Million-97.35%
2012-C$4.29 Million6.23%
2011-C$4.04 Million-18.59%
2010-C$4.96 Million-11.37%
2009-C$5.6 Million98.4%
2008-C$2.83 Million156.15%
2007-C$1.11 Million-59.36%
2006-C$2.71 Million17.92%
2005-C$2.3 Million37.7%
2004-C$1.67 Million25.51%
2003-C$1.33 Million-289.84%
2002C$0.7 M-1605.88%
2001-C$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.22 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$24.84 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA